Treatment of AML by inhibitors of NHR2 and/or RUNX1/ETO-tetramerization provides a therapy option with a unique mode of action.
[更多]
"SEI-forming Electrolyte additive 3" describes a substance as an electrolyte additive and a process for forming an SEI (Solid Electrolyte Interphase) film for lithium-ion batteries. According to the invention, the compound 6,6-difluoro-1,2,4-thiadiazinane-3,5-dione 1,1-dioxide is added to the electr.....
[更多]
CPAP–tubulin as a novel target in cancer therapy and first-in-substances inhibiting pseudoclustering of centrosomes as drugs for this target.
[更多]
The here presented technology allows to separate polarizable bioparticles, such as bacteria, from each other and to cultivate them individually under controlled environmental conditions. By employing negative dielectrophoresis (nDEP) via special electrodes cells can be trapped contactless in a flow .....
[更多]
Treatment of osteoporosis by inhibitors of sphingosine-1-phosphatase (S1P)-lyase.
[更多]
| |< <- | [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] | -> >| |
